Compounded Semaglutide vs Wegovy
Compare compounded semaglutide vs Wegovy, including FDA approval status, pharmacy questions, salt-form concerns, dosing support, and safety checks.
compounded semaglutide vs WegovyQuick Answer: Compounded Semaglutide vs Wegovy
Wegovy is an FDA-approved product for specific uses, while compounded semaglutide is not FDA-approved. FDA warnings advise patients and providers to be careful with unapproved GLP-1 products used for weight loss.
Ask a licensed provider to explain the medication route, pharmacy, dosing, and why that route is being considered.
- FDA-approved and compounded products are not interchangeable labels.
- Salt forms, dosing instructions, and vial/syringe use can create safety confusion.
- Shortage status and pharmacy legitimacy should be verified before payment.
Quick answer
Wegovy is an FDA-approved1 semaglutide product for chronic weight management in certain patients. Compounded semaglutide is not FDA-approved and does not go through FDA premarket review for safety, effectiveness, or quality.
Consumer guidance: This is exactly where readers deserve plain language. A lower price or faster access claim should not replace basic questions about approval status, pharmacy, dosing, and provider oversight.
Personalized GLP-1 Eligibility Check: Before comparing medication routes, answer a few private questions to see whether provider review is a reasonable next step.
Find Out if Your Profile Matches Provider Guidelines in 60 SecondsFDA-Approved vs. Compounded GLP-1 Options
Use this quick comparison to weigh the decision behind Compounded Semaglutide vs Wegovy in plain English, including the safer first step, what can be missed, and when provider review should come before payment.
| Question | What It Means |
|---|---|
| FDA-approved medication | Reviewed by FDA for specific indications, labeling, dosing, safety information, and manufacturing standards. |
| Compounded medication | Not FDA-approved; may be considered only under specific conditions and requires careful provider and pharmacy review. |
| Generic medication | Not the same as compounded. FDA-approved generics must meet FDA standards; compounded GLP-1s are not FDA-approved generics. |
Potential advantages of a clear medication route
- Makes it easier to understand what medication is being discussed.
- Helps compare labeling, dosing, pharmacy, and follow-up support.
Questions to ask before continuing
- Avoid language that implies compounded drugs are identical to FDA-approved products.
- Ask who prescribes, which pharmacy prepares medication, and how side effects are handled.
Not sure where you stand? After you understand the basics, take the 2-minute eligibility assessment to see whether a provider-guided next step may fit.
Key takeaways
- Ask whether the medication is FDA-approved or compounded.
- Ask which pharmacy fulfills it and whether salt forms are involved.
- Review FDA warnings before choosing by price alone.
- Start with the full compounded GLP-1 guide for the full context.
Wegovy and compounded semaglutide are not the same thing. Wegovy is an FDA-approved branded semaglutide product for chronic weight management in certain patients. Compounded semaglutide is prepared by a pharmacy and is not FDA-approved.
Because the difference affects safety, sourcing, cost, and expectations, read this comparison alongside the full compounded GLP-1 guide.
The core difference
The most important distinction is approval status. FDA-approved medications are reviewed for approved uses, labeling, manufacturing, and quality standards. Compounded drugs can have a role for specific patient needs, but compounded GLP-1 products are not FDA-approved and are not reviewed the same way before marketing.
Questions compounded programs should answer
If a program discusses compounded semaglutide, ask what exact ingredient is used, whether it is a salt form, what pharmacy prepares it, how dosing is taught, how storage and shipping are handled, and who manages side effects. FDA has specifically raised concerns about salt forms, dosing errors, improper shipping temperatures, and fraudulent compounded products.
How to decide what to read next
Read the compounded GLP-1 guide before comparing costs. Then read the safe clinic checklist and cost page. A low price may look attractive, but the real decision should include safety, transparency, and provider supervision.
Questions to ask before your next step
- Who reviews my intake and are they licensed for my state?
- What exact medication type or route is being discussed?
- What pharmacy or prescription channel is used?
- What side-effect and follow-up support is included?
- What total cost should I expect over three to six months?
Frequently Asked Questions
Is compounded semaglutide the same as Wegovy?
No. Wegovy is FDA-approved for specific uses; compounded semaglutide is not FDA-approved.
Is compounded semaglutide always unsafe?
In some cases, yes. Compounding can have a role in specific patient needs, but compounded GLP-1 drugs require careful provider and pharmacy review.
What are semaglutide salt forms?
FDA has warned that semaglutide sodium and semaglutide acetate are different active ingredients from those in approved drugs.
What should I ask a telehealth provider?
Ask about ingredient form, pharmacy, dosing, storage, side-effect support, and follow-up.
Before You Take the Eligibility Quiz
- Struggling to lose weight with diet changes alone?
- Want to see whether a GLP-1 path may fit your health history?
- Looking for a transparent online provider review process?
Take the free 2-minute eligibility assessment to see which questions deserve provider review.
Take the 2-Minute Eligibility QuizReady to compare a provider-guided option?
Use the educational guides first. If you decide to continue, an online quiz pre-check is only a first step; a licensed provider determines whether treatment is appropriate.
Watch the 60-Second Visual Explainer
This short vertical explainer summarizes the decision in plain English before you compare programs or take the eligibility quiz.
Compounded GLP-1s: What to VerifyCompounded GLP-1s: What to verify before trusting a program Not FDA-approved copies: Compounded GLP-1 drugs are not reviewed like FDA-approved products. Shortage status matters: Some compounding pathways changed as semaglutide and tirzepatide supply stabilized. Verify the pharmacy: Ask for pharmacy name, license, ingredient form, dosing, storage, and support. Slow down before payment: A lower price should not replace provider review or pharmacy transparency.
Why Shortages Changed the Conversation
- Demand for GLP-1 medications created access pressure in recent years.
- FDA shortage status affects when certain compounded copies may be treated differently under compounding rules.
- Because status can change, verify current FDA shortage information and ask the provider why a compounded route is being discussed.
